Literature DB >> 21092057

Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma.

Lucia Restano1, Daniele Fanoni, Cristiana Colonna, Carlo Gelmetti, Emilio Berti.   

Abstract

Medallion-like dermal dendrocyte hamartoma is a rare congenital lesion, comprised of a benign dermal proliferation of fusiform cells that stain positive for CD34, often positive for factor XIIIa, and negative for S100. It has a highly characteristic clinical presentation consisting of a well-circumscribed atrophic and wrinkled patch located on the upper trunk or neck that remains stable with time. We report a case of an 11-year-old boy with a typical medallion-like dermal dendrocyte hamartoma on the nape of the neck that was previously misdiagnosed as neurofibroma on the basis of initial histological examination that was later reevaluated due to lack of clinical correlation. Three previously-reported cases of medallion-like dermal dendrocyte hamartoma also have had a previous histological misdiagnosis of probable neurofibroma; other reported cases have been misdiagnosed as congenital atrophic dermatofibrosarcoma protuberans. Clinical correlation and immunostaining are particularly important for the recognition of this rare benign lesion.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21092057     DOI: 10.1111/j.1525-1470.2010.01324.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Medallion-like dermal dendrocyte hamartoma: differential diagnosis with congenital atrophic dermatofibrosarcoma protuberans.

Authors:  Minseok Cheon; Kyung Eun Jung; Hei Sung Kim; Jun Young Lee; Hyung-Ok Kim; Chan Kum Park; Young Min Park
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

2.  Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement.

Authors:  Maki Makino; Shunsuke Sasaoka; Gen Nakanishi; Eiichi Makino; Wataru Fujimoto
Journal:  Diagn Pathol       Date:  2016-03-01       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.